| Literature DB >> 31577812 |
Évelin Maria Brand1, Maíra Rossetto2, Karen da Silva Calvo1, Gerson Barreto Winkler1, Daila Alena Raenck da Silva3, Bruna Hentges4, Frederico Viana Machado1, Erica Rosalba Mallmann Duarte3, Lucas Cardoso da Silva1, Samantha Correa Vasques1, Luciana Barcellos Teixeira1.
Abstract
BACKGROUND: TB/HIV coinfection is a serious public health issue in Brazil, and patients with coinfection have difficulty adhering to treatments. Directly observed treatment (DOT) has been recommended by the World Health Organization, considering the vulnerability of those affected. The purpose is to investigate the occurrence of DOT and associated factors compared to conventional treatment in Porto Alegre, Brazil.Entities:
Year: 2019 PMID: 31577812 PMCID: PMC6774507 DOI: 10.1371/journal.pone.0222786
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sociodemographic characteristics and numbers receiving directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.
| Characteristics | Total | Receiving DOT | p-value | |
|---|---|---|---|---|
| Yes | No | |||
| <0.001 | ||||
| 2009 | 398 (16.6%) | 37 (9.3%) | 361 (90.7%) | |
| 2010 | 408 (17%) | 44 (10.8%) | 364 (89.2%) | |
| 2011 | 494 (20.6%) | 48 (9.7%) | 446 (90.3%) | |
| 2012 | 525 (21.9%) | 95 (18.1%) | 430 (81.9%) | |
| 2013 | 575 (24%) | 182 (31.7%) | 393 (68.3%) | |
| < 0.001 | ||||
| CEN | 427 (17.8%) | 111(26%) | 316 (74%) | |
| NHNI | 158 (6.6%) | 17 (10.8%) | 141 (89.2%) | |
| NEB | 263 (11%) | 26 (9.9%) | 237 (90.1%) | |
| LENO | 376 (15.7%) | 57 (15.2%) | 319 (84.8%) | |
| GCC | 285 (11.9%) | 40 (14%) | 245 (86%) | |
| SCS | 168 (7%) | 16 (9.5%) | 152 (90.5%) | |
| PLP | 550 (22.9%) | 112 (20.4%) | 438 (79.6%) | |
| RES | 171 (7.1%) | 27 (15.8%) | 144 (84.2%) | |
| 38±9.9 | 37.8±9.2 | 38±10 | 0.766 | |
| <0.001 | ||||
| White | 1346 (56.3%) | 196 (14.6%) | 1.150 (85.4%) | |
| Non-white | 1046 (43.7%) | 209 (20%) | 837 (80%) | |
| 0.457 | ||||
| Male | 1574 (65.6%) | 273 (17.3%) | 1.301 (82.7%) | |
| Female | 826 (34.4%) | 133 (16.1%) | 693 (83.9%) | |
| 0.021 | ||||
| ≤7 years | 1536 (69.2%) | 282 (18.4%) | 1254 (81.6%) | |
| 8–11 years | 625 (28.2%) | 88 (14.1%) | 537 (85.9%) | |
| ≥12 years | 59 (2.7%) | 6 (10.2%) | 53 (89.8%) | |
*Proportion homogeneity test based on Pearson’s chi-square statistic or **Fischer’s exact test.
***T-student test for independent samples.
aDOT = Directly observed therapy.
bTotal data may differ due to the possibility of the non-response by participants.
cDistrict Health Authorities (DHA) = CEN: Centro, NEB: North/Baltazar Axis, LENO: East/Northeast, GCC: Gloria/Cruzeiro/Cristal, SCS: South/Center-South, PLP: Partenon/Lomba do Pinheiro, RES: Restinga/South End, NHNI: Northwest/Humaitá/Navegantes/Ilhas.
dNon-white population is the sum of the colored population (black and brown), alongside Asians and indigenous people.
Clinical and follow-up characteristics and the occurrence of directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.
| Characteristics | Total | Receiving DOT | p-value | |
|---|---|---|---|---|
| Yes | No | |||
| <0.001* | ||||
| New case | 1382 (57.6%) | 175 (12.7%) | 1207 (87.3%) | |
| Relapse | 347 (14.5%) | 65 (18.7%) | 282 (81.3%) | |
| Readmission after default | 615 (25.6%) | 146 (23.7%) | 469 (76.3%) | |
| Transfer | 56 (2.3%) | 20 (35.7%) | 36 (64.3%) | |
| 0.279* | ||||
| Suspicion | 2137 (89.2%) | 366 (17.1%) | 1771 (82.9%) | |
| Normal | 56 (2.3%) | 9 (16.1%) | 47 (83.9%) | |
| Other pathology | 29 (1.2%) | 1 (3.4%) | 28 (96.6%) | |
| Not performed | 173 (7.2%) | 29 (16.8%) | 144 (83.2%) | |
| 0.002* | ||||
| Positive | 1414 (58.9%) | 268 (19%) | 1146 (81%) | |
| Negative | 687 (28.6%) | 105 (15.3%) | 582 (84.7%) | |
| Not performed | 299 (12.5%) | 33 (11%) | 266 (89%) | |
| 0.003* | ||||
| Positive | 1001 (41.7%) | 195 (19.5%) | 806 (80.5%) | |
| Negative | 661 (27.6%) | 112 (16.9%) | 549 (83.1%) | |
| Not performed | 736 (30.7%) | 98 (13.3%) | 638 (86.7%) | |
| <0.001** | ||||
| Yes | 618 (25.8%) | 318 (51.5%) | 300 (48.5%) | |
| No | 1778 (74.2%) | 87 (4.9%) | 1691 (95.1%) | |
| <0.001** | ||||
| Yes | 613 (25.6%) | 149 (24.3%) | 464 (75.7%) | |
| No | 1784 (74.4%) | 257 (14.4%) | 1527 (85.6%) | |
| 0.508** | ||||
| Yes | 66 (2.8%) | 13 (19.7%) | 53 (80.3%) | |
| No | 2330 (97.2%) | 392 (16.8%) | 1938 (83.2%) | |
| <0.001** | ||||
| Yes | 97 (4.1%) | 34 (35.1%) | 63 (64.9%) | |
| No | 2297 (95.9%) | 370 (16.1%) | 1927 (83.9%) | |
| <0.001* | ||||
| Cure | 852 (35.7%) | 148 (17.4%) | 704 (82.6%) | |
| Default | 855 (35.8%) | 159 (18.6%) | 696 (81.4%) | |
| Death | 532 (22.2%) | 54 (10.2%) | 478 (89.8%) | |
| Transfer | 87 (3.6%) | 18 (20.7%) | 69 (79.3%) | |
| MDR-TB | 62 (2.6%) | 22 (35.5%) | 40 (64.5%) | |
Homogeneity of proportions test based on Pearson’s chi-square statistic* or Fischer’s exact test**.
aDOT = Directly observed therapy,
btotal data may differ due to the possibility of the non-response by participants,
cAFB test = acid-fast bacilli test,
dMDR-TB = Multidrug-resistant TB.
Factors associated with directly observed therapy in patients with TB/HIV coinfection in Porto Alegre, 2009–2013.
| Characteristics | Receiving DOT | p-value | |
|---|---|---|---|
| Crude OR | Adjusted OR | ||
| 2009 | 1.00 | 1.00 | |
| 2010 | 1.16 (0.77–1.76) | 1.16 (0.77–1.74) | 0.489 |
| 2011 | 1.05 (0.69–1.57) | 0.94 (0.62–1.42) | 0.759 |
| 2012 | 1.95 (1.36–2.78) | 1.64 (1.14–2.35) | 0.007 |
| 2013 | 3.41 (2.45–4.73) | 2.89 (2.07–4.05) | <0.001 |
| CEN | 2.73 (1.67–4.47) | 2.28 (1.38–3.76) | 0.001 |
| NHNI | 1.13 (0.59–2.16) | 1.13 (0.60–2.13) | 0.703 |
| NEB | 1.04 (0.57–1.88) | 0.87 (0.48–1.59) | 0.659 |
| LENO | 1.59 (0.94–1.69) | 1.29 (0.76–2.19) | 0.343 |
| GCC | 1.47 (0.85–2.55) | 1.34 (0.78–2.31) | 0.296 |
| SCS | 1.00 | 1.00 | |
| PLP | 2.14 (1.30–3.51) | 1.72 (1.04–2.85) | 0.033 |
| RES | 1.66 (0.93–2.96) | 1.72 (0.97–3.06) | 0.064 |
| White | 1.00 | 1.00 | |
| Non-white | 1.37 (1.15–1.64) | 1.29 (1.08–1.54) | 0.006 |
| ≤7 years | 1.81 (0.84–3.88) | 1.52 (0.70–3.27) | 0.289 |
| 8–11 years | 1.39 (0.63–3.03) | 1.29 (0.59–2.79) | 0.524 |
| ≥12 years | 1.00 | 1.00 | |
| New case | 1.00 | 1.00 | |
| Relapse | 1.48 (1.14–1.92) | 1.33 (1.03–1.72) | 0.026 |
| Readmission after default | 1.88 (1.54–2.29) | 1.48 (1.20–1.83) | <0.001 |
| Transfer | 2.82 (1.93–4.12) | 2.04 (1.40–2.98) | <0.001 |
| Positive | 1.72 (1.22–2.41) | 1.73 (1.24–2.42) | 0.001 |
| Negative | 1.00 | 1.00 | |
| Not performed | 1.39 (0.96–1.99) | 1.48 (1.04–2.85) | 0.032 |
| Yes | 1.69 (1.41–2.02) | 1.39 (1.16–1.67) | <0.001 |
| No | 1.00 | 1.00 | |
| Yes | 2.18 (1.63–2.89) | 1.83 (1.38–2.44) | <0.001 |
| No | 1.00 | 1.00 | |
aDOT = Directly observed therapy,
bunivariate models,
cmulti-variable model by the logistic regression method,
dDistrict Health Authorities (DHA) = CEN: Centro, NEB: North/Baltazar Axis, LENO: East/Northeast, GCC: Gloria/Cruzeiro/Cristal, SCS: South/Center-South, PLP: Partenon/Lomba do Pinheiro, RES: Restinga/South End, NHNI: Northwest/Humaitá/Navegantes/Ilhas.